December 18, 2024
1 min read
The top retina articles on Healio this year included updates on pegcetacoplan in Europe, encapsulated cell therapy for macular telangiectasia type 2 and the rapid diagnosis of retinal artery occlusion.
Check out 2024’s top retina items below.
Pegcetacoplan for geographic atrophy receives negative opinion from European committee
In January, the Committee for Medicinal Products for Human Use of the European Medicines Agency issued a negative opinion on a marketing authorization application for pegcetacoplan. Read more.
En face OCT identifies cRORA as hypertransmission defects
Analyzing en face OCT images for hypertransmission defects can quickly identify complete retinal pigment epithelium and outer retinal atrophy, according to a presentation at Angiogenesis, Exudation, and Degeneration 2024. Read more.
Protocol shows potential for rapid diagnosis of retinal artery occlusion
A novel protocol utilizing OCT imaging and a remote consult model showed promise in rapidly diagnosing retinal artery occlusion. Read more.
Macular telangiectasia cell therapy meets primary endpoints in phase 3 trials
NT-501, an encapsulated cell therapy for the treatment of macular telangiectasia type 2, met its primary endpoints across two phase 3 trials, according to a speaker at Retina 2024. Read more.
Real-world study investigates effects of GLP-1 agonists on diabetic retinopathy
There are conflicts in the literature concerning the association of Ozempic with increased risk or worsening of diabetic retinopathy. Read more.
Read more about
Leave a Reply